Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06096051 · ClinicalTrials.gov registry record
Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 76
- Enrollment target
NCT06096051 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 76 participants.
The verdict
NCT06096051 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
Intracranial hemorrhage (ICH) can occur due to traumatic and spontaneous events.1 The incidence of non-traumatic, spontaneous ICH is approximately 40,000 to 67,000 cases per year while the incidence of traumatic brain injury (TBI) is nearly 1.7 million annually
Interventions
- PROCEDURE Use of fixed-dosed 4F-PCC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2023-06-13 |
| Est. Completion | 2024-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06096051
The ClinicalTrials.gov registry entry for NCT06096051 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of fixed-dosed 4F-PCC is the first listed.
NCT06096051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06096051 about?
NCT06096051 is a clinical study titled "Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage". Intracranial hemorrhage (ICH) can occur due to traumatic and spontaneous events.1 The incidence of non-traumatic, spontaneous ICH is approximately 40,000 to 67,000 cases per year while the incidence of traumatic brain injury (TBI) is nearly 1.7 million annually
What is the current status of trial NCT06096051?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2023-06-13. Estimated completion is 2024-06-17.
What interventions are being tested in trial NCT06096051?
The interventions under investigation include: Use of fixed-dosed 4F-PCC (PROCEDURE).
Who is sponsoring clinical trial NCT06096051?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.